Bradykinin induces the bi-phasic production of lysophosphatidyl inositol and diacylglycerol in a dorsal root ganglion X neurotumor hybrid cell line, F-11. 1988

P Francel, and G Dawson
Department of Pharmacological & Physiological Sciences, University of Chicago, IL 60637.

Bradykinin acts on the dorsal root ganglion X neuroblastoma hybrid cell line F-11 to stimulate the rapid elevation of inositol trisphosphate (IP3) and intracellular calcium. We now show an equally rapid release of arachidonyl labeled diacylglycerol (DAG), (243 +/- 32% of control). This first peak of diacylglycerol production was inhibitable by either pretreatment with 200 ng/ml of pertussis toxin overnight or by 10 nM tetradecanoylphorbol acetate (TPA). In addition, a second, more sustained release occurred, plateauing at approximately five minutes (304 +/- 16%). The second peak of DAG was unaffected by these TPA or pertussis pre-incubations. Simultaneous analysis of inositol-labeled phospholipids showed that the initial IP3 and DAG peaks corresponded to initial decreases in phosphoinositides PIP2 and PIP whereas PI increased slightly over this same time period. In contrast, at 5-30 minutes, PIP2 and PIP returned to normal levels, but PI gradually decreased to 75% of control values. Likewise, TPA blocked this early PIP and PIP2 breakdown, but had no effect on the delayed breakdown of monophosphatidylinositol (PI). Bradykinin also induced an equally rapid increase in lysophosphatidyl inositol (lyso-PI) with a peak around 10-30 seconds, and a second more sustained peak after 10 minutes. This production of lyso-PI was not affected by prior treatment with TPA or pertussis toxin. The initial and the sustained phases of diacylglycerol production probably result from different biochemical mechanisms and/or substrates.

UI MeSH Term Description Entries
D007295 Inositol Phosphates Phosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID. Inositol Phosphate,Phosphate, Inositol,Phosphates, Inositol
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008246 Lysophospholipids Derivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal. Lysophosphatidic Acids,Lysophospholipid,Acids, Lysophosphatidic
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004075 Diglycerides Glycerides composed of two fatty acids esterified to the trihydric alcohol GLYCEROL. There are two possible forms that exist: 1,2-diacylglycerols and 1,3-diacylglycerols. Diacylglycerol,Diacylglycerols
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations

Related Publications

P Francel, and G Dawson
February 1990, Brain research. Developmental brain research,
P Francel, and G Dawson
April 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Copied contents to your clipboard!